![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0026.jpg)
Top 5 DR Capital Raisings
1
(in USD Millions)
DR Trading Value
1,2
$1,358
TAIWAN
CHINA
INDIA
JAPAN
SOUTH KOREA
OTHER
HONG KONG
AUSTRALIA
72
%
2
%
2
%
5
%
6
%
6
%
6
%
1
%
CTrip.comInternational Ltd.
ZTO Express Inc.
Line Corporation
BeiGene, Ltd.
GDS Holdings Ltd.
$192
$382
$894
$1,406
$1,506
Asia-Pacific
Highlights
Capital Raisings
•
$4.8 billion
in DR
capital raised
•
56%
via IPOs
•
44%
via follow-on offerings
Trading Volume
• Down
16%
from 2015
to
36.8 billion
• Unsponsored trading
volume down
8%
to
1.4 billion
New DR Programs
•
20
new sponsored programs
•
8
on NASDAQ
•
6
on OTC
•
3
on NYSE
•
3
GDR programs
“Due to a record low IPO
year in 2016, we are seeing
strong pent-up demand in
several Asian countries and
especially in China. We are
especially optimistic for
the fintech and biopharma
sectors in 2017.”
Valentina Chuang
Head of Asia Pacific
Total DR Trading Value: $1,158.7B
Asia-Pacific Snapshot
26